Identification of a long-sought ADP receptor on platelets explains the effects of two drugs used to prevent strokes and heart attacks. It also points the way to developing other such drugs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hollopeter, G. et al. Nature 409, 202–207 (2001).
Daniel, J. L. et al. J. Biol. Chem. 273, 2024– 2029 (1998).
Jin, J. G. et al. J. Biol. Chem. 273, 2030– 2034 (1998).
Cattaneo, M. & Gachet, C. Arterioscler. Thromb. Vasc. Biol. 19, 2281–2285 ( 1999).
Fabre, J. E. et al. Nature Med. 5, 1199– 1202 (1999).
Léon, C. et al. J. Clin. Invest. 104, 1731– 1737 (1999).
Offermanns, S. et al. Nature 389, 183–186 (1997).
Mahaut-Smith, M. P. et al. Br. J. Pharmacol. 131, 108– 114 (2000).
Bennett, C. L. et al. New. Engl. J. Med. 342, 1773– 1777 (2000).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brass, S. Small cells, big issues. Nature 409, 145–147 (2001). https://doi.org/10.1038/35051688
Issue Date:
DOI: https://doi.org/10.1038/35051688
This article is cited by
-
Clopidogrel and risk for acute coronary events
Current Atherosclerosis Reports (2007)
-
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
Nature Neuroscience (2006)
-
Scientific and therapeutic advances in antiplatelet therapy
Nature Reviews Drug Discovery (2003)
-
The role of the adapter molecule SLP-76 in platelet function
Oncogene (2001)